Search

agbiopro
- Aug 3
- 0 min read

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

Industry deals

4 views

Recent Posts

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

1Write a comment

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

1Write a comment

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

2Write a comment